The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
Ohio State University · with Irrimax Corporation · NCT07239219
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- January 1, 2026
- Record last updated
- July 31, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Being studied: 0.05% Chlorhexidine Gluconate; Normal Saline
Conditions: Urinary Tract Infection; Antibiotic; Catheter Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Presenting to the urology clinic for catheter removal
- Must be 18 years or older.
- The patient must be able to understand and willing to provide informed consent as described in this study protocol.
- Must be willing to complete a post-catheter removal survey
Exclusion Criteria
- Allergy or adverse reaction to chlorohexidine gluconate
- Under the age of 18
- Refuse to provide informed consent
- On antibiotic therapy for any indication.
- Women who are pregnant or breastfeeding
- Signs of skin or systemic infection
- Patients undergoing catheter exchange
Recruiting US locations
The Ohio State University
Columbus, OH 43212-3153
Site contact: Hiren Patel, MD, PhD · 6142938155 · hiren.patel@osumc.edu
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75